Rapidly Progressive Pulmonary Fibrosis in a Patient Treated with Danazol for Idiopathic Thrombocytopenic Purpura
article
OA: gold
CC0
⤵ 2 in-corpus citations
Abstract
The case of a patient that developed pulmonary fibrosis two months after initiation of danazol for treatment of idiopathic thrombocytopenic purpura is described. Bilateral pneumothoraxes and pneumomediastinum complicated the rapidly fatal pulmonary fibrosis. An association between danazol therapy and the development of pulmonary fibrosis is suspected. There is only one other case report with this connection in the literature.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (4)
- Fatal acute pulmonary fibrosis in a patient treated by danazol for thrombocytopenia 1996
- A study of danazol's safety. 1996
- Long-term danazol administration 1996
- Fatal acute pulmonary fibrosis in a patient treated by danazol for thrombocytopenia 1996
Cited by (2)
References (10)
- A study of danazol's safety. via openalex
- Fatal acute pulmonary fibrosis in a patient treated by danazol for thrombocytopenia via openalex
- Fatal acute pulmonary fibrosis in a patient treated by danazol for thrombocytopenia via openalex
- Long-term danazol administration via openalex
- W6683879455 via openalex
- doi:10.1016/s0015-0282(16)53638-3 via openalex
- doi:10.1164/ajrccm.165.2.ats01 via openalex
- W72553817 via openalex
- W2736080073 via openalex
- W6635217874 via openalex
Cited by (2)
Source provenance
- openalex
- last seen: 2026-05-10T10:40:25.691325+00:00
License: CC0
· commercial use OK